Product
Get the ingredient, exact brand, pack and authorised purpose in writing.
Injection library
MariTide (development name). Maridebart cafraglutide, commonly called MariTide, uses a different long-acting design from currently authorised weekly GLP-1 products.
Quick facts
What it is
Maridebart cafraglutide, commonly called MariTide, uses a different long-acting design from currently authorised weekly GLP-1 products.
No approved medical use. Phase 3 MARITIME studies are ongoing.
Why people search it
Its less-frequent development schedule and trial results attract comparisons that are premature before full regulatory review.
Search popularity does not establish safety, quality, eligibility or availability.
Turkey context
There is no standard retail or clinic treatment pathway for an investigational medicine.
Get the ingredient, exact brand, pack and authorised purpose in writing.
Verify the named clinician and why the medicine fits your clinical context.
Use a licensed pharmacy and keep the original carton, leaflet and receipt.
Agree who monitors treatment and supply after you return home.
Safety boundary
A product borrowing the MariTide name is not proof of identity, quality or authorisation.
Common questions
No approved medical use. Phase 3 MARITIME studies are ongoing.
There is no standard retail or clinic treatment pathway for an investigational medicine.
MariTide (development name). Brand names, indications and availability vary by jurisdiction; confirm the exact product rather than relying on the ingredient name alone.
Do not buy prescription or investigational injections from social media, informal sellers or unverified websites. A product borrowing the MariTide name is not proof of identity, quality or authorisation.
Primary reference